anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

158,641-158,700 of 319,975

filter-aware
68
The slide uses color coding to distinguish between highlighted medicines and other pipeline medicines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
69
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
70
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
71
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
72
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
73
Includes speaker names and titles, date, and webinar registration link.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
74
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
75
The slide uses a three-column layout to contrast disease statistics with clinical evidence for treatment.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
76
Slide uses a split-layout comparing two distinct product strategies (COPD vs Asthma).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
77
The slide uses a combination of donut charts for market penetration and a grouped bar chart for clinical trial efficacy data.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
78
The slide uses a matrix-like structure to map biological mechanisms to specific drug candidates and development timelines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
79
The slide uses a three-column layout to present distinct clinical trial outcomes.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
80
The slide uses a color-coded legend to distinguish highlighted presentation items from other pipeline medicines.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
81
Includes a screenshot of a Zoom-like meeting toolbar.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
82
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
83
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
84
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
85
The slide is a continuation of a list of publications, specifically focusing on the PATHWAY study.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
86
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
Bausch Health Companies | Investor Conference Presentation Deck | 10 slidesBausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations 1 hit
02
Bausch Health Companies | Investor Conference Presentation Deck | 10 slidesBausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations 1 hit
03
The slide uses a matrix structure to map drug candidates against development stages.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Problem1 hit
04
Includes footnote references for licensing and S1P definition.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Product1 hit
05
Bausch Health Companies | Investor Conference Presentation Deck | 10 slidesBausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Product1 hit
06
The slide outlines the clinical development strategy for a specific drug formulation.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Product1 hit
07
The slide outlines a drug development pipeline from preclinical to NDA submission.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
08
Bausch Health Companies | Investor Conference Presentation Deck | 10 slidesBausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
09
The slide outlines the therapeutic rationale and clinical roadmap for a specific drug candidate.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Beat · Solution1 hit
10
The slide uses a grid-based timeline layout to track multiple drug development programs simultaneously.Bausch Health Companies | Investor Conference Presentation Deck | 10 slides · Bausch Health
Conference presentation Investor relations Loop · Why Now1 hit
01
Slide 1
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · What Is1 hit
02
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · What Is1 hit
03
Standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · What Is1 hit
04
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · What Is1 hit
05
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
06
The slide uses a 2x3 grid layout to present organizational milestones.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
07
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
08
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key Takeaways1 hit
09
Uses a three-stage temporal framework (Today, Tomorrow, The Future) to illustrate strategic expansion.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
10
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
11
Includes citations for clinical trial data.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
12
The slide highlights vaccine efficacy metrics (97% and 94%) against various COVID-19 outcomes.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
13
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
14
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
15
The slide uses a linear process flow to demonstrate the speed of the manufacturing cycle.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
16
Includes a table of regional orders and a map of manufacturing sites in the US and Europe.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
17
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
18
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities target cancer and modulate the immune system.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Key MessagesLoop · Cost Of Inaction1 hit
19
The slide uses a timeline-style visual representation within a table structure to show development stages.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
20
The slide uses a four-column layout to categorize different therapeutic modalities, each with associated clinical programs and status indicators.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
21
Includes a citation of a Science paper and a structural diagram of the CAR construct.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
22
The slide uses a process diagram to show production and a combination of anatomical illustration and a line chart to show the mechanism of action and therapeutic effect.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Timeline1 hit
23
The slide uses a process flow diagram to illustrate the trial structure from patient selection to expansion cohorts.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
24
The slide uses a comparison framework to contrast the pharmacokinetic profile of recombinant cytokines (spiky) vs RiboCytokines (sustained).BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
25
The diagram uses a staircase visual for dose levels and horizontal arrows for expansion cohorts.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
26
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit
27
The table shows revenue, operating expenses, and profit/loss figures in millions of Euros.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
28
The chart uses a stacked bar to decompose total revenue into four distinct categories, with a bracket highlighting the COVID-19 specific portion.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
29
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
30
Includes footnote clarifying tax loss carryforwards.BioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations Beat · Appendix Data1 hit
31
BioNTech | Results Presentation Deck | 36 slidesBioNTech | Results Presentation Deck | 36 slides · BioNTech
Conference presentation Investor relations 1 hit